Cipla, Kemwell Biopharma join hands to develop biosimilars

Under the terms of the agreement, the joint venture will leverage Cipla and Kemwell’s complementary strengths for end-to-end product development, clinical development, regulatory filings, manufacturing and commercialisation of biopharmceutical products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3DcCx6J
via IFTTT